Phreesia, Inc. (NYSE:PHR - Get Free Report) CFO Balaji Gandhi sold 864 shares of the stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $21.03, for a total value of $18,169.92. Following the completion of the sale, the chief financial officer now owns 97,714 shares of the company's stock, valued at approximately $2,054,925.42. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Balaji Gandhi also recently made the following trade(s):
- On Tuesday, September 10th, Balaji Gandhi sold 3,502 shares of Phreesia stock. The stock was sold at an average price of $23.25, for a total value of $81,421.50.
Phreesia Stock Down 2.2 %
NYSE:PHR opened at $20.40 on Friday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.77 and a current ratio of 1.77. The firm has a market cap of $1.17 billion, a P/E ratio of -9.40 and a beta of 0.93. Phreesia, Inc. has a fifty-two week low of $12.05 and a fifty-two week high of $29.16. The firm has a 50-day simple moving average of $23.36 and a two-hundred day simple moving average of $22.44.
Add $2T of Potential Magic to Your Portfolio
From Elf Labs | Ad
Revolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But it’s very much within reach for a company with the rights to some of the highest grossing characters in history like Cinderella, Snow White, Peter Pan, and more.
Become an Elf Labs shareholder by 10/30.
Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings data on Wednesday, September 4th. The company reported ($0.31) earnings per share for the quarter, topping analysts' consensus estimates of ($0.37) by $0.06. The company had revenue of $102.12 million during the quarter, compared to analyst estimates of $101.76 million. Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. Analysts predict that Phreesia, Inc. will post -1.23 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the business. Capital International Investors increased its holdings in Phreesia by 221.1% in the 1st quarter. Capital International Investors now owns 2,593,063 shares of the company's stock worth $62,052,000 after buying an additional 1,785,463 shares in the last quarter. Champlain Investment Partners LLC bought a new stake in shares of Phreesia in the first quarter worth approximately $29,941,000. Blair William & Co. IL raised its holdings in shares of Phreesia by 42.6% during the first quarter. Blair William & Co. IL now owns 752,700 shares of the company's stock valued at $18,012,000 after purchasing an additional 224,950 shares during the last quarter. Vanguard Group Inc. lifted its position in Phreesia by 4.4% during the fourth quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company's stock valued at $107,148,000 after purchasing an additional 194,035 shares during the period. Finally, Deerfield Management Company L.P. Series C bought a new position in Phreesia during the second quarter valued at approximately $4,078,000. 92.10% of the stock is owned by institutional investors.
Analyst Ratings Changes
PHR has been the topic of a number of research analyst reports. Robert W. Baird boosted their price objective on shares of Phreesia from $31.00 to $34.00 and gave the company an "outperform" rating in a research report on Friday, September 6th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $23.00 price objective on shares of Phreesia in a research report on Friday, September 27th. Needham & Company LLC reiterated a "buy" rating and set a $29.00 target price on shares of Phreesia in a report on Thursday, September 5th. JPMorgan Chase & Co. raised their target price on Phreesia from $27.00 to $28.00 and gave the company an "overweight" rating in a research note on Monday, September 9th. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $30.00 price target on shares of Phreesia in a research note on Thursday, September 5th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, Phreesia presently has a consensus rating of "Moderate Buy" and a consensus target price of $29.42.
Read Our Latest Report on Phreesia
Phreesia Company Profile
(
Get Free Report)
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
